A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular degeneration (or "wet" AMD) fail to have vision ...

"Astellas stands by the clinical profile of Izervay, the only FDA-approved GA treatment that consistently demonstrated ...

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

In 2003 his right eye developed wet age-related macular degeneration ... he was one of five chosen for a clinical trial of Lucentis, a new drug just approved by the FDA to treat the wet form ...

This growth in the Age-Related Macular Degeneration market is fueled by ... in research and development investments that lead to more drug approvals and improved reimbursement policies.

Age-Related Macular Degeneration market growth analysis. PORTLAND, OR, UNITED STATES, November 21, 2024 /EINPresswire / -- Increase in prevalence of age-re ...